Skip to main content
Now Approved Icon

Contact Us

Medical Information Center

Thank you for your interest in contacting Janssen Products, LP. Please note that we can only provide information about products marketed within the United States, and must refer international inquiries to our affiliates. For additional information, please contact Janssen Medical Information by using one of the following methods:

  • Phone: Call 1-800-JANSSEN (1-800-526-7736)
  • Email: Submit questions via our askjanssenmedinfo.com site
  • Search: JanssenMD Image

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

INDICATION

YONDELIS® (trabectedin) is indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.

 

Important Safety Information

 

Indication

INDICATION

YONDELIS® (trabectedin) is indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.

Error Message Icon

Please hold your device
in the portrait position.